French IP Lawyers Prefer No Favours For Green Tech Patents; Welcome America Invents Act 20/03/2012 by Catherine Saez, Intellectual Property Watch Leave a Comment PARIS – A meeting of IP professionals held in Paris last week reaffirmed the importance of intellectual property and its protection to the private sector. Meanwhile, panellists at the event argued that green technologies should not benefit from a special regime. They also hailed the new America Invents Act as facilitating patent applications in the United States.
Singapore Seeks To Liberalise Patent Law In Bid To Become IP Hub 16/03/2012 by Maricel Estavillo for Intellectual Property Watch 1 Comment South-east Asia’s economic juggernaut Singapore will hold a public consultation on a proposal to liberalise its patent law in a bid to cement its position as the intellectual property (IP) hub in the region.
Intérêt de l’entreprise et choix stratégiques : les licences concédées par Gilead au Medicines Patent Pool 14/03/2012 by Intellectual Property Watch Leave a Comment Bien que Gilead ait apporté des améliorations considérables à ses précédentes licences volontaires portant sur des médicaments antirétroviraux essentiels, les licences que l’entreprise a concédées au Medicines Patent Pool, fondation créée par UNITAID, comportent des restrictions regrettables qui fragilisent leur impact sur l’accès à des antirétroviraux génériques de qualité garantie plus abordables dans les pays en développement.
WIPO To Discuss Role Of Patents In Access To Water 14/03/2012 by Intellectual Property Watch 1 Comment The World Intellectual Property Organization has waded into the global debates over access to safe drinking water, with an upcoming workshop on patents and water purification technologies.
WIPO Sets Record For International Patent Filings In 2011; LDCs Not A Factor 05/03/2012 by William New, Intellectual Property Watch Leave a Comment The World Intellectual Property Organization today announced that it had set a new record for filings of patents at the international level in 2011, in what the UN agency attributed to a focus on innovation. Patents filed under the WIPO-managed Patent Cooperation Treaty shot up more than 10 per cent last year in the fastest growth since 2005, and a Chinese company took top honour for most filings.
Special Report: TPP Negotiations To Heat Up In Melbourne Over Patents, Copyright, Medicines 21/02/2012 by Liza Porteus Viana, Intellectual Property Watch 1 Comment Precious little is known publicly about the details of the Trans-Pacific Partnership (TPP) agreement being negotiated by the United States and other Pacific-bordering nations, but some sources say the agreement could contain some of the strongest language on intellectual property rights that has come under attack in other agreements. US trade negotiators, meanwhile, say they are consulting stakeholders widely.
Microsoft Says It Will Not Act On Patents In Standards 13/02/2012 by Intellectual Property Watch Leave a Comment Microsoft Corporation has issued a statement that it will not seek injunctions on its standard essential patents in keeping with its promises to international standards organisations. It further said it will make those essential patents available for licence without condition.
USPTO Launches ‘Patents For Humanity’ Prize Project 08/02/2012 by William New, Intellectual Property Watch 3 Comments The United States Patent and Trademark Office today announced a project it said will award prizes to patent owners for using their patented technology for humanitarian purposes worldwide.
Another Indian Generics Company Signs With Patent Pool 02/02/2012 by Intellectual Property Watch Leave a Comment A leading supplier of generic antiretroviral medicines has signed an agreement to manufacture new HIV medicines for sale in developing countries, the Medicines Patent Pool announced today.
European Commission Orders Italy To Drop Patent Linkage Delaying Generics 31/01/2012 by Intellectual Property Watch Leave a Comment The European Commission has issued a formal request to Italy to remove linkage between patents and generic medicines authorisation that it says is causing delays in generics reaching the market.